Exelixis
EXEL
#1683
Rank
โ‚น853.27 B
Marketcap
โ‚น2,988
Share price
1.62%
Change (1 day)
68.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company